Xeloda is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by State Of Florida Doh Central Pharmacy. The primary component is Capecitabine.
Product ID | 53808-0411_15601703-7442-48f3-89f4-44fef66b7514 |
NDC | 53808-0411 |
Product Type | Human Prescription Drug |
Proprietary Name | Xeloda |
Generic Name | Capecitabine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2009-07-01 |
Marketing Category | NDA / NDA |
Application Number | NDA020896 |
Labeler Name | State of Florida DOH Central Pharmacy |
Substance Name | CAPECITABINE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2009-07-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020896 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2009-07-01 |
Inactivation Date | 2019-10-21 |
Ingredient | Strength |
---|---|
CAPECITABINE | 500 mg/1 |
SPL SET ID: | a732b303-9bbd-42ba-a7c5-61c21629ba93 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0004-1100 | Xeloda | capecitabine |
0004-1101 | Xeloda | capecitabine |
53808-0411 | Xeloda | Xeloda |
0054-0271 | Capecitabine | Capecitabine |
0054-0272 | Capecitabine | Capecitabine |
0093-7473 | Capecitabine | Capecitabine |
0093-7474 | Capecitabine | Capecitabine |
0378-2511 | Capecitabine | capecitabine |
0378-2512 | Capecitabine | capecitabine |
16714-467 | CAPECITABINE | CAPECITABINE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XELODA 75241696 2200434 Live/Registered |
Hoffmann-La Roche Inc. 1997-02-13 |